Molecular diagnostics of the coronavirus disease of 2019 (COVID-19) now mainly relies on
the measurements of viral RNA by RT-PCR, or detection of anti-viral antibodies by …

Rapid but yet sensitive, specific, and high-throughput detection of the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) in clinical samples is key to diagnose …

Coronavirus disease 2019 (COVID-19) is a worldwide pandemic. To understand the
changes in plasma proteomics upon SARS-CoV-2 infection, we analyzed the protein profiles …

Background Survivors of acute COVID-19 often suffer prolonged, diffuse symptoms post-
infection, referred to as “Long-COVID”. A lack of Long-COVID biomarkers and …

Despite the scientific and human efforts to understand COVID-19, there are questions still
unanswered. Variations in the metabolic reaction to SARS-CoV-2 infection could explain the …

Abstract Coronavirus disease 2019 (COVID-19), caused by an outbreak of the severe acute
respiratory syndrome-coronavirus 2 (SARS-CoV-2) in Wuhan, China, has led to an …

Mass spectrometry (MS) is one of the key technologies used in proteomics. The majority of
studies carried out using proteomics have focused on identifying proteins in biological …

Background. The COVID‐19 pandemic caused by the SARS‐CoV‐2 virus has resulted in a
global health crisis with significant morbidity and mortality. While effective vaccinations have …

Pandemics create havoc in human life and are not simply old-world problems. A series of
recent viral outbreaks including HIV, influenza, Ebola, Zika, and SARS-CoV-2 have elevated …

Human infectious diseases are contributed equally by the host immune system's efficiency
and any pathogens' infectivity. Severe acute respiratory syndrome coronavirus 2 (SARS …